Hear the latest news in Parkinson's research from Foundation and field leaders. Our panelists will look ahead to treatments up for approval soon, new trials starting early next year and a major expansion of our landmark PPMI study to enable preventive therapies. We'll also discuss initiatives to better understand Parkinson's genetics across populations. Panelists and MJFF staff will answer questions from the audience throughout the hour.